These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10463380)

  • 1. Citalopram, a selective serotonin reuptake inhibitor, improves symptoms of Friedreich's ataxia.
    Rohr A; Eichler K; Hafezi-Moghadam N
    Pharmacopsychiatry; 1999 May; 32(3):113-4. PubMed ID: 10463380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C; Stein DJ
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram: a rapid-onset selective serotonin reuptake inhibitor?
    Crow S; Daly KA; Fatemi SH; MacGraw R; Meller W
    Can J Psychiatry; 1999 Dec; 44(10):1051-2. PubMed ID: 10637688
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.
    Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C
    Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
    Libri V; Yandim C; Athanasopoulos S; Loyse N; Natisvili T; Law PP; Chan PK; Mohammad T; Mauri M; Tam KT; Leiper J; Piper S; Ramesh A; Parkinson MH; Huson L; Giunti P; Festenstein R
    Lancet; 2014 Aug; 384(9942):504-13. PubMed ID: 24794816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L; Jensen R; Olesen J
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    van Kerkhoven LA; Laheij RJ; Jansen JB
    Gut; 2007 May; 56(5):733; author reply 733. PubMed ID: 17440190
    [No Abstract]   [Full Text] [Related]  

  • 8. Idebenone in Friedreich's ataxia.
    Tonon C; Lodi R
    Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram versus other selective serotonin-reuptake inhibitors.
    Thomas KV; Holimon TD
    Am J Health Syst Pharm; 1999 Nov; 56(21):2242-4. PubMed ID: 10565706
    [No Abstract]   [Full Text] [Related]  

  • 11. Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia.
    Taiminen TJ; Syvälahti E; Saarijärvi S; Niemi H; Lehto H; Ahola V; Salokangas RK
    Int Clin Psychopharmacol; 1997 Jan; 12(1):31-5. PubMed ID: 9179631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
    Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
    J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram and sexual side effects of selective serotonin reuptake inhibitors.
    Pallanti S; Koran LM
    Am J Psychiatry; 1999 May; 156(5):796. PubMed ID: 10327919
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond depression: citalopram for obsessive-compulsive disorder.
    Pato MT
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S19-26. PubMed ID: 10471169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's ataxia. Revision of the phenotype according to molecular genetics.
    Schöls L; Amoiridis G; Przuntek H; Frank G; Epplen JT; Epplen C
    Brain; 1997 Dec; 120 ( Pt 12)():2131-40. PubMed ID: 9448568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of Friedreich's ataxia with amantadine hydrochloride.
    Peterson PL; Saad J; Nigro MA
    Neurology; 1988 Sep; 38(9):1478-80. PubMed ID: 3412597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram in anorexia nervosa.
    Pallanti S; Quercioli L; Ramacciotti A
    Eat Weight Disord; 1997 Dec; 2(4):216-21. PubMed ID: 14655831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical interactions with antidepressives. Benefits of the specific serotonin reuptake inhibitor citalopram].
    Eckert A; Reiff J; Müller WE
    Med Monatsschr Pharm; 1998 May; 21(5):138-50. PubMed ID: 9617102
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.